NAN Share Price Performance
AU$3.82
0.83 (27.76%)
36.2% undervalued intrinsic discount
AU$5.98
Fair Value
Price AU$3.82
AnalystHighTarget AU$5.98
AnalystConsensusTarget AU$4.64
AnalystLowTarget AU$3.75
Fair ValueAU$5.98
Share PriceAU$3.82
36.2% undervalued intrinsic discount
NAN Community Narratives
AN
Fair Value AU$5.98 36.2% undervalued intrinsic discount
Rising Global Health Trends Will Expand Automated Disinfection Markets
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value AU$4.64 17.6% undervalued intrinsic discount
European Expansion And CORIS System Launch Will Strengthen Market Position
1users have liked this narrative
1users have commented on this narrative
24users have followed this narrative
AN
Fair Value AU$3.75 1.9% overvalued intrinsic discount
Rising Regulatory Hurdles Will Strain Global Disinfection Markets
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
NAN Community Fair Values
- AU$4.64FV17.6% undervalued intrinsic discount10.97%Revenue growth p.a.1users have liked this narrative1users have commented on this narrative24users have followed this narrative4 days ago author updated this narrative
- AU$5.98FV36.2% undervalued intrinsic discount13.62%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrative12 days ago author updated this narrative
- AU$3.75FV1.9% overvalued intrinsic discount11.70%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrative17 days ago author updated this narrative
Recent NAN News & Updates
No updates
Nanosonics Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.055
- Gross Margin
- 77.42%
- Net Profit Margin
- 9.00%
- Debt/Equity Ratio
- 0%
Nanosonics Limited Competitors
About NAN
- Founded
- 2000
- Employees
- 466
- CEO
- WebsiteView website
Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Australian Market Performance
- 7 Days: -0.2%
- 3 Months: 6.6%
- 1 Year: 8.6%
- Year to Date: 5.1%
Over the last 7 days, the market has remained flat, although notably the Materials sector declined by 4.2%. As for the longer term, the market has risen 8.6% in the past 12 months. Earnings are forecast to grow by 11% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading